Research has shown that CCNB2 is often increased in HBV‐associated HCC and breast cancer, as well as in other human cancers such as lung and liver cancer, and its dysregulation may result in uncontrolled cell proliferation, promoting tumor formation.26 Here, CCNB2 is linked to hepatocellular carcinoma.